Alane P. Barnes, Chief Legal Officer at BIOCRYST PHARMACEUTICALS INC (BCRX), sold 150,000 shares at $9.15 ($1.4M) on 2026-03-16, disclosed to the SEC on 2026-03-18.
Scheduled sale ($1.4M) by Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| BCRX | SELL | 2025-12-16 | $325K | — | Filing → |
| BCRX | SELL | 2025-12-03 | $2.3M | — | Filing → |
| BCRX | BUY | 2024-05-15 | $28K | — | Filing → |